# Krispy Kreme, Inc.: financial statements, quarterly

DNUT · Nasdaq · CIK 1857154 · [Consumer staples](/sectors/consumer-staples.md)

Pages: [Overview](/companies/dnut.md) · [Financials](/companies/dnut/financials.md) · [Filings](/companies/dnut/filings.md) · [Insiders](/companies/dnut/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dnut/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [407](/filings/0001857154-24-000113.md) | [451 d](/filings/0001857154-26-000015.md) | [443](/filings/0001857154-25-000073.md) | [439](/filings/0001857154-25-000131.md) | [380](/filings/0001857154-25-000140.md) | [404 d](/filings/0001857154-26-000015.md) | [375](/filings/0001857154-26-000029.md) | [380](/filings/0001857154-26-000046.md) | [375](/filings/0001857154-25-000140.md) | [392 d](/filings/0001857154-26-000015.md) | [367](/filings/0001857154-26-000029.md) | [331](/filings/0001857154-26-000046.md) |
| Selling, general and administrative | $m | [68.3](/filings/0001857154-24-000113.md) | [74.5 d](/filings/0001857154-26-000015.md) | [71.6](/filings/0001857154-25-000073.md) | [64.5](/filings/0001857154-25-000131.md) | [71.1](/filings/0001857154-25-000140.md) | [67.2 d](/filings/0001857154-26-000015.md) | [59.4](/filings/0001857154-26-000029.md) | [62.9](/filings/0001857154-26-000046.md) | [49.4](/filings/0001857154-25-000140.md) | [54.6 d](/filings/0001857154-26-000015.md) | [58.0](/filings/0001857154-26-000029.md) | [53.7](/filings/0001857154-26-000046.md) |
| Operating income | $m | [(2.1)](/filings/0001857154-24-000113.md) | [(5.3) d](/filings/0001857154-26-000015.md) | [11.9](/filings/0001857154-25-000073.md) | [6.9](/filings/0001857154-25-000131.md) | [(16.0)](/filings/0001857154-25-000140.md) | [(11.5) d](/filings/0001857154-26-000015.md) | [(20.3)](/filings/0001857154-26-000029.md) | [(435)](/filings/0001857154-26-000046.md) | [(7.2)](/filings/0001857154-25-000140.md) | [(7.3) d](/filings/0001857154-26-000015.md) | [(3.6)](/filings/0001857154-26-000029.md) | [(11.0)](/filings/0001857154-26-000046.md) |
| Income tax | $m | [24.4](/filings/0001857154-24-000113.md) | [(21.5) d](/filings/0001857154-26-000015.md) | [4.3](/filings/0001857154-25-000073.md) | [(3.6)](/filings/0001857154-25-000131.md) | [17.7](/filings/0001857154-25-000140.md) | [(2.4) d](/filings/0001857154-26-000015.md) | [(2.7)](/filings/0001857154-26-000029.md) | [(20.5)](/filings/0001857154-26-000046.md) | [(2.8)](/filings/0001857154-25-000140.md) | [5.1 d](/filings/0001857154-26-000015.md) | [3.6](/filings/0001857154-26-000029.md) | [(4.3)](/filings/0001857154-26-000046.md) |
| Net income | $m | [(40.5)](/filings/0001857154-24-000113.md) | [2.6 d](/filings/0001857154-26-000015.md) | [(8.5)](/filings/0001857154-25-000073.md) | [(5.5)](/filings/0001857154-25-000131.md) | [39.6](/filings/0001857154-25-000140.md) | [(22.4) d](/filings/0001857154-26-000015.md) | [(33.3)](/filings/0001857154-26-000029.md) | [(435)](/filings/0001857154-26-000046.md) | [(19.4)](/filings/0001857154-25-000140.md) | [(27.8) d](/filings/0001857154-26-000015.md) | [(22.8)](/filings/0001857154-26-000029.md) | [(20.3)](/filings/0001857154-26-000046.md) |
| Diluted EPS | $ per share | [(0.24)](/filings/0001857154-24-000113.md) | not reported | [(0.05)](/filings/0001857154-25-000073.md) | [(0.03)](/filings/0001857154-25-000131.md) | [0.23](/filings/0001857154-25-000140.md) | not reported | [(0.22)](/filings/0001857154-26-000029.md) | [(2.55)](/filings/0001857154-26-000046.md) | [(0.11)](/filings/0001857154-25-000140.md) | not reported | [(0.16)](/filings/0001857154-26-000029.md) | [(0.12)](/filings/0001857154-26-000046.md) |
| Basic EPS | $ per share | [(0.24)](/filings/0001857154-24-000113.md) | not reported | [(0.05)](/filings/0001857154-25-000073.md) | [(0.03)](/filings/0001857154-25-000131.md) | [0.23](/filings/0001857154-25-000140.md) | not reported | [(0.22)](/filings/0001857154-26-000029.md) | [(2.55)](/filings/0001857154-26-000046.md) | [(0.11)](/filings/0001857154-25-000140.md) | not reported | [(0.16)](/filings/0001857154-26-000029.md) | [(0.12)](/filings/0001857154-26-000046.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.7](/filings/0001857154-24-000113.md) | [38.2](/filings/0001857154-26-000015.md) | [33.1](/filings/0001857154-25-000073.md) | [28.6](/filings/0001857154-25-000131.md) | [25.4](/filings/0001857154-25-000140.md) | [29.0](/filings/0001857154-26-000015.md) | [18.7](/filings/0001857154-26-000029.md) | [21.3](/filings/0001857154-26-000046.md) | [30.7](/filings/0001857154-25-000140.md) | [42.4](/filings/0001857154-26-000046.md) | [74.2](/filings/0001857154-26-000029.md) | [21.8](/filings/0001857154-26-000046.md) |
| Current assets | $m | [160](/filings/0001857154-23-000114.md) | [174](/filings/0001857154-25-000013.md) | [174](/filings/0001857154-24-000063.md) | [168](/filings/0001857154-24-000090.md) | [164](/filings/0001857154-24-000113.md) | [173](/filings/0001857154-26-000015.md) | [158](/filings/0001857154-25-000073.md) | [155](/filings/0001857154-25-000131.md) | [162](/filings/0001857154-25-000140.md) | [174](/filings/0001857154-26-000046.md) | [187](/filings/0001857154-26-000029.md) | [165](/filings/0001857154-26-000046.md) |
| Total assets | $m | [3,187](/filings/0001857154-23-000114.md) | [3,241](/filings/0001857154-25-000013.md) | [3,234](/filings/0001857154-24-000063.md) | [3,223](/filings/0001857154-24-000090.md) | [3,065](/filings/0001857154-24-000113.md) | [3,072](/filings/0001857154-26-000015.md) | [3,089](/filings/0001857154-25-000073.md) | [2,630](/filings/0001857154-25-000131.md) | [2,600](/filings/0001857154-25-000140.md) | [2,593](/filings/0001857154-26-000046.md) | [2,387](/filings/0001857154-26-000029.md) | [2,363](/filings/0001857154-26-000046.md) |
| Current liabilities | $m | [525](/filings/0001857154-23-000114.md) | [526](/filings/0001857154-25-000013.md) | [490](/filings/0001857154-24-000063.md) | [494](/filings/0001857154-24-000090.md) | [475](/filings/0001857154-24-000113.md) | [486](/filings/0001857154-26-000015.md) | [449](/filings/0001857154-25-000073.md) | [458](/filings/0001857154-25-000131.md) | [449](/filings/0001857154-25-000140.md) | [457](/filings/0001857154-26-000046.md) | [446](/filings/0001857154-26-000029.md) | [465](/filings/0001857154-26-000046.md) |
| Total liabilities | $m | [1,938](/filings/0001857154-23-000114.md) | [1,977](/filings/0001857154-25-000013.md) | [1,986](/filings/0001857154-24-000063.md) | [1,994](/filings/0001857154-24-000090.md) | [1,856](/filings/0001857154-24-000113.md) | [1,908](/filings/0001857154-26-000015.md) | [1,958](/filings/0001857154-25-000073.md) | [1,912](/filings/0001857154-25-000131.md) | [1,906](/filings/0001857154-25-000140.md) | [1,916](/filings/0001857154-26-000046.md) | [1,753](/filings/0001857154-26-000029.md) | [1,744](/filings/0001857154-26-000046.md) |
| Long-term debt | $m | [827](/filings/0001857154-23-000114.md) | [837](/filings/0001857154-24-000113.md) | [882](/filings/0001857154-24-000063.md) | [895](/filings/0001857154-24-000090.md) | [805](/filings/0001857154-24-000113.md) | [845](/filings/0001857154-25-000140.md) | [935](/filings/0001857154-25-000073.md) | [889](/filings/0001857154-25-000131.md) | [906](/filings/0001857154-25-000140.md) | [912](/filings/0001857154-26-000046.md) | [830](/filings/0001857154-26-000029.md) | [794](/filings/0001857154-26-000046.md) |
| Current portion of debt | $m | [43.5](/filings/0001857154-23-000114.md) | [54.6](/filings/0001857154-24-000113.md) | [60.3](/filings/0001857154-24-000063.md) | [59.8](/filings/0001857154-24-000090.md) | [47.6](/filings/0001857154-24-000113.md) | [56.4](/filings/0001857154-25-000140.md) | [54.6](/filings/0001857154-25-000073.md) | [67.6](/filings/0001857154-25-000131.md) | [73.3](/filings/0001857154-25-000140.md) | [66.0](/filings/0001857154-26-000046.md) | [58.7](/filings/0001857154-26-000029.md) | [71.0](/filings/0001857154-26-000046.md) |
| Shareholders' equity | $m | [1,152](/filings/0001857154-23-000114.md) | [1,170](/filings/0001857154-25-000013.md) | [1,153](/filings/0001857154-24-000063.md) | [1,135](/filings/0001857154-24-000090.md) | [1,180](/filings/0001857154-24-000113.md) | [1,135](/filings/0001857154-26-000015.md) | [1,102](/filings/0001857154-25-000073.md) | [694](/filings/0001857154-25-000131.md) | [670](/filings/0001857154-25-000140.md) | [650](/filings/0001857154-26-000046.md) | [632](/filings/0001857154-26-000029.md) | [618](/filings/0001857154-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.2) d](/filings/0001857154-24-000113.md) | [1.5 d](/filings/0001857154-26-000015.md) | [(17.7)](/filings/0001857154-25-000073.md) | [33.2 d](/filings/0001857154-25-000131.md) | [3.3 d](/filings/0001857154-25-000140.md) | [27.0 d](/filings/0001857154-26-000015.md) | [(20.8)](/filings/0001857154-26-000029.md) | [(32.5) d](/filings/0001857154-26-000046.md) | [42.3 d](/filings/0001857154-25-000140.md) | [45.0 d](/filings/0001857154-26-000015.md) | [20.2](/filings/0001857154-26-000029.md) | [(10.2) d](/filings/0001857154-26-000046.md) |
| Capital expenditure | $m | [34.3 d](/filings/0001857154-24-000113.md) | [32.8 d](/filings/0001857154-26-000015.md) | [29.1](/filings/0001857154-25-000073.md) | [31.7 d](/filings/0001857154-25-000131.md) | [26.1 d](/filings/0001857154-25-000140.md) | [33.9 d](/filings/0001857154-26-000015.md) | [25.9](/filings/0001857154-26-000029.md) | [28.2 d](/filings/0001857154-26-000046.md) | [26.7 d](/filings/0001857154-25-000140.md) | [17.1 d](/filings/0001857154-26-000015.md) | [8.8](/filings/0001857154-26-000029.md) | [7.3 d](/filings/0001857154-26-000046.md) |
| Dividends paid | $m | [5.9 d](/filings/0001857154-24-000113.md) | [5.9 d](/filings/0001857154-26-000015.md) | [5.9](/filings/0001857154-25-000073.md) | [5.9 d](/filings/0001857154-25-000131.md) | [5.9 d](/filings/0001857154-25-000140.md) | [5.9 d](/filings/0001857154-26-000015.md) | [6.0](/filings/0001857154-26-000029.md) | [6.0 d](/filings/0001857154-26-000046.md) | [0.0 d](/filings/0001857154-25-000140.md) | [0.0 d](/filings/0001857154-26-000015.md) | [0.0](/filings/0001857154-26-000029.md) | [0.0 d](/filings/0001857154-26-000046.md) |
| Share repurchases | $m | [1.5 d](/filings/0001857154-24-000113.md) | [0.3 d](/filings/0001857154-26-000015.md) | [0.8](/filings/0001857154-25-000073.md) | [3.5 d](/filings/0001857154-25-000131.md) | [0.1 d](/filings/0001857154-25-000140.md) | [1.1 d](/filings/0001857154-26-000015.md) | [0.1](/filings/0001857154-26-000029.md) | [0.7 d](/filings/0001857154-26-000046.md) | [0.4 d](/filings/0001857154-25-000140.md) | [0.2 d](/filings/0001857154-26-000015.md) | [0.4](/filings/0001857154-26-000029.md) | [0.1 d](/filings/0001857154-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [167](/filings/0001857154-23-000114.md) | [168](/filings/0001857154-24-000063.md) | [171](/filings/0001857154-24-000090.md) | [168](/filings/0001857154-24-000113.md) | [169](/filings/0001857154-25-000073.md) | [169](/filings/0001857154-25-000131.md) | [171](/filings/0001857154-25-000140.md) | [170](/filings/0001857154-26-000029.md) | [171](/filings/0001857154-26-000046.md) | [171](/filings/0001857154-25-000140.md) | [172](/filings/0001857154-26-000029.md) | [173](/filings/0001857154-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 173,500,000 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001857154-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.